|
Volumn 47, Issue 7, 2012, Pages 536-539
|
[Clinical analysis of nimotuzumab plus cisplatin and fluorouracil regimen as induction treatment in resectable head and neck squamous cell carcinoma].
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
FLUOROURACIL;
MONOCLONAL ANTIBODY;
NIMOTUZUMAB;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
FEMALE;
HEAD AND NECK TUMOR;
HUMAN;
MALE;
MIDDLE AGED;
MULTIMODALITY CANCER THERAPY;
SQUAMOUS CELL CARCINOMA;
ADOLESCENT;
ADULT;
AGED;
ANTIBODIES, MONOCLONAL, HUMANIZED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, SQUAMOUS CELL;
CISPLATIN;
COMBINED MODALITY THERAPY;
FEMALE;
FLUOROURACIL;
HEAD AND NECK NEOPLASMS;
HUMANS;
MALE;
MIDDLE AGED;
YOUNG ADULT;
|
EID: 84874912720
PISSN: 16730860
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (10)
|
References (0)
|